Forest Must Resolve Breakpoint Issues On Road To Ceftaroline Approval

Negotiation of breakpoints appears to be the final hurdle as Forest Laboratories seeks approval for ceftaroline fosamil to treat serious skin infections and community-acquired bacterial pneumonia.